Report pursuant to the Danish Securities Trading Act, Section 28a


To NASDAQ OMX Copenhagen A/S
Announcement no. 16-14 / Copenhagen, July 1, 2014

Pursuant to the Danish Securities Trading Act, Section 28a this is to report the following transactions by members of Topotarget A/S’ board of directors and senior management as well as their related parties concerning shares issued by Topotarget A/S and related securities.

 

Name Bo Jesper Hansen
Reason for reporting Chairman of the board of directors
Issuer and ISIN code Topotarget A/S, DK0060003556
Transaction Subscription of shares through exercise of warrants
Trade Date July 1, 2014
Market Nasdaq OMX, Copenhagen
Number of shares 200,000
Market value in DKK DKK 554,500 based on an average subscription price of DKK 2.775 per share
   
Name Anker Lundemose
Reason for reporting Board member
Issuer and ISIN code Topotarget A/S, DK0060003556
Transaction Subscription of shares through exercise of warrants
Trade Date July 1, 2014
Market Nasdaq OMX, Copenhagen
Number of shares 100,000
Market value in DKK DKK 277,500 based on an average subscription price of DKK 2.775 per share
   
Name Gisela Schwab
Reason for reporting Board member
Issuer and ISIN code Topotarget A/S, DK0060003556
Transaction Subscription of shares through exercise of warrants
Trade Date July 1, 2014
Market Nasdaq OMX, Copenhagen
Number of shares 75,000
Market value in DKK DKK 189,500 based on an average subscription price of DKK 2.526 per share
   
Name Ingelise Saunders
Reason for reporting Board member
Issuer and ISIN code Topotarget A/S, DK0060003556
Transaction Subscription of shares through exercise of warrants
Trade Date July 1, 2014
Market Nasdaq OMX, Copenhagen
Number of shares 113,769
Market value in DKK DKK 321,561 based on an average subscription price of DKK 2.826 per share
   
Name Jeffrey Buchalter
Reason for reporting Board member
Issuer and ISIN code Topotarget A/S, DK0060003556
Transaction Subscription of shares through exercise of warrants
Trade Date July 1, 2014
Market Nasdaq OMX, Copenhagen
Number of shares 113,769
Market value in DKK DKK 321,561 based on an average subscription price of DKK 2.826 per share
   
Name Karsten Witt
Reason for reporting Board member
Issuer and ISIN code Topotarget A/S, DK0060003556
Transaction Subscription of shares through exercise of warrants
Trade Date July 1, 2014
Market Nasdaq OMX, Copenhagen
Number of shares 75,000
Market value in DKK DKK 189,500 based on an average subscription price of DKK 2.526 per share
   
Name Anders Fink Vadsholt
Reason for reporting CEO
Issuer and ISIN code Topotarget A/S, DK0060003556
Transaction Subscription of shares through exercise of warrants
Trade Date July 1, 2014
Market Nasdaq OMX, Copenhagen
Number of shares 650,000
Market value in DKK DKK 1,807,500 based on an average subscription price of 2.7807 per share

 

 

Topotarget A/S

For further information, please contact:
Anders Vadsholt, CEO – direct: +45 39178345

Background information

About Topotarget
Topotarget (NASDAQ OMX: TOPO) is a Danish-based biopharmaceutical company headquartered in Copenhagen, Denmark, dedicated to the clinical development and registration of oncology products. In collaboration with Spectrum Pharmaceuticals, Inc., Topotarget focuses on the development of its lead drug candidate, belinostat, which has shown positive results in the treatment of hematological malignancies and solid tumors, obtained by both mono- and  combination therapy. For more information, please refer to www.topotarget.com.

Topotarget Safe Harbor Statement
This announcement may contain forward-looking statements, including statements about Topotarget A/S’ expectations to the progression of Topotarget A/S’ clinical pipeline and with respect to cash burn guidance. Such statements are subject to risks and uncertainties of which many are outside the control of Topotarget A/S, and which could cause actual results to differ materially from those described. Topotarget A/S disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by Danish law.


Attachments

Announcement no. 16-14 Report pursuant to the Danish Securities Trading Act, Section 28a.pdf